| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
42,456 |
32,682 |
$2.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,757 |
19,033 |
$1000K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
22,411 |
17,342 |
$916K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
19,496 |
14,513 |
$483K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
40,471 |
29,145 |
$377K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40,928 |
30,014 |
$331K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,802 |
2,467 |
$329K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
32,429 |
24,632 |
$242K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,182 |
2,315 |
$130K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,838 |
2,767 |
$81K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,532 |
2,034 |
$70K |
| 87428 |
|
1,372 |
1,148 |
$54K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,486 |
4,163 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,020 |
1,485 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,081 |
711 |
$20K |
| 99051 |
|
13,321 |
9,849 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
140 |
122 |
$11K |
| 99000 |
|
17,906 |
13,223 |
$11K |
| 87631 |
|
73 |
60 |
$4K |
| 94760 |
|
2,242 |
1,811 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
88 |
62 |
$2K |
| S9083 |
Global fee urgent care centers |
7,548 |
4,719 |
$1K |
| 86769 |
|
31 |
26 |
$754.32 |
| 99058 |
|
25 |
25 |
$503.57 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
65 |
31 |
$471.44 |
| 86328 |
|
17 |
14 |
$463.15 |
| 96127 |
|
27 |
25 |
$80.07 |
| 36416 |
|
19 |
15 |
$0.00 |
| 99001 |
|
17 |
16 |
$0.00 |